Plain-English translation of NCT03358693 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →Researchers are trying to understand why some people with inflammatory skin conditions like eczema and psoriasis respond better to certain medications than others. This study collects blood and skin samples from patients already taking approved treatments—including , , and several others—to look for biological markers that might predict who will benefit most from each medication.
Currently, doctors don't have a reliable way to predict which treatment will work best for each individual patient, so people sometimes try several medications before finding one that helps. By identifying biological patterns in blood and skin, researchers hope to eventually make treatment selection faster and more personalized.
You likely qualify if…
You likely don't qualify if…
If you join, you'll have blood drawn and a small skin sample collected during study visits. Researchers will analyze these samples using advanced genetic and immune testing to look for patterns that match your disease type and how well you're responding to your current medication. The exact number and timing of visits isn't specified in the trial information, so you'd need to ask the study team for details about the commitment.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Germany